Reverse merger of Flerie Invest AB (SE) and InDex Pharmaceuticals – SEK 3,073 million Healthcare Reverse merger of Flerie Invest AB (SE) and InDex Pharmaceuticals – SEK 3,073 million
Directed new share issue in Flerie AB (SE) — SEK 607 million Healthcare Directed new share issue in Flerie AB (SE) — SEK 607 million
Placing of shares in RVRC Holding AB (SE) — SEK 400 million Consumer & Retail Placing of shares in RVRC Holding AB (SE) — SEK 400 million
Senior secured bond tap issue by SIBS AB (SE) – SEK 100 million Real Estate Senior secured bond tap issue by SIBS AB (SE) – SEK 100 million
Placing of shares in Truecaller AB (SE) — SEK 518 million TMT Placing of shares in Truecaller AB (SE) — SEK 518 million
Sale of Helios Nordic Energy AB (SE) to VINCI Concessions (FR) Cleantech, Renewables & Infrastructure Sale of Helios Nordic Energy AB (SE) to VINCI Concessions (FR)
Rights issue in Lyckegård Group AB (SE) — SEK 28 million Cleantech, Renewables & Infrastructure Rights issue in Lyckegård Group AB (SE) — SEK 28 million
Directed share issue in Irisity AB (SE) – SEK 45 million TMT Directed share issue in Irisity AB (SE) – SEK 45 million
Public cash offer to ChromoGenics AB (SE) Cleantech, Renewables & Infrastructure Public cash offer to ChromoGenics AB (SE)
Combined directed share issue and secondary sell-down in Emilshus AB (SE) – SEK 585 million Real Estate Combined directed share issue and secondary sell-down in Emilshus AB (SE) – SEK 585 million
Directed share issue in Nyfosa AB – SEK 1.734 billion Real Estate Directed share issue in Nyfosa AB – SEK 1.734 billion
Private placement in Xshore AB (SE) — SEK 100 million Cleantech, Renewables & Infrastructure Private placement in Xshore AB (SE) — SEK 100 million